Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 1

Explore clinical trials studying Diabetes Mellitus, Type 1. Study availability and eligibility vary by location and protocol.

881 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 1 trial results

Completed

Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus.

NCT00424437

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
Locations
  • Pfizer Investigational Site Burlingame, California, United States
  • Pfizer Investigational Site Irvine, California, United States
  • Pfizer Investigational Site Newport Beach, California, United States
  • Pfizer Investigational Site San Diego, California, United States
View all 36 locations
View Trial Details
Completed

Six Month Clinical Trial Assessing Efficacy and Safety of Inhaled Insulin in Type 1 Diabetes

NCT00424333

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
Locations
  • Pfizer Investigational Site Duarte, California, United States
  • Pfizer Investigational Site Long Beach, California, United States
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site Stanford, California, United States
View all 35 locations
View Trial Details
Completed

Local Registration Trial in China Humalog Mix 50

NCT00191581

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Beijing, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Guangzhou, China
View Trial Details
Completed

Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients

NCT00034255

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations
  • VASDHS Medical Center San Diego, California, United States
  • MedStar Research Institute - Clinical Research Center Washington D.C., District of Columbia, United States
  • UNC Diabetes, Endocrinology, Metabolism Clinic Durham, North Carolina, United States
  • Texas Diabetes Institute San Antonio, Texas, United States
View Trial Details
Active, Not Recruiting

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

NCT06334133

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
Locations
  • Scottsdale Clinical Trials Scottsdale, Arizona, United States
  • Baptist Health Center for Clinical Research Little Rock, Arkansas, United States
  • Amicis Research Center Granada Hills, California, United States
  • AME Clinical Research Huntington Beach, California, United States
View all 52 locations
View Trial Details
Active, Not Recruiting

A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar

NCT07160816

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
Locations
  • Hausärztliche und Diabetologische Praxis Pirna Pirna, LÄK Sachsen, Germany
  • Zuckerpraxis Dr. Ewald Jammers Bramsche, Germany
  • Studiengesellschaft Dres. Könemann/Steinmann GbR Bünde, Germany
  • Diabeteszentrum-Do Dres. K U. Ch. Busch GbR Dortmund, Germany
View all 37 locations
View Trial Details

Related conditions